Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect
about
Herbal medicines and nonalcoholic fatty liver diseaseDoes bilirubin prevent hepatic steatosis through activation of the PPARα nuclear receptor?Lowering the dietary omega-6: omega-3 does not hinder nonalcoholic fatty-liver disease development in a murine model.Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPARα/LPL and LDLRNon-alcoholic fatty liver disease and diabetes.New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver DiseaseActivation of Sterol Regulatory Element Binding Factors by Fenofibrate and Gemfibrozil Stimulates Myelination in Zebrafish.Fenofibrate, but not ezetimibe, prevents fatty liver disease in mice lacking phosphatidylethanolamine N-methyltransferaseSake lees extract improves hepatic lipid accumulation in high fat diet-fed mice.Metabolic adaptation to intermittent fasting is independent of peroxisome proliferator-activated receptor alpha.Anti-hyperlipidemic effect of rice bran polysaccharide and its potential mechanism in high-fat diet mice.Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue.Multi-scale, whole-system models of liver metabolic adaptation to fat and sugar in non-alcoholic fatty liver disease
P2860
Q26738524-CF9CFFCD-9F74-44C7-AF34-7B56D975D0F7Q33693385-F20190AF-83BD-4848-9665-1D3C459E7786Q35670899-D66F457F-69F2-4DB1-853F-F288DC1E6565Q35689614-DA609024-085E-4829-B6BD-891425F43346Q37091659-8776FD88-52EA-4C30-AB77-A349AAE78B4DQ37604102-94C43086-3AB4-4F8F-B414-FC38218BB37DQ38444377-D351164F-89C2-42BD-BD41-A2C73A539A5EQ41776542-2B89E580-6CBA-43DC-8C7B-EAA1FDB3006AQ42091299-1FEBE5B6-A0E3-44D0-8C27-5F68C1A62636Q47394446-66CC6F41-34E6-4C7F-88DC-2923AE1243E7Q47720428-CB38509E-DEAE-4932-A3CD-5409DD8610F5Q52338665-02E8BB9D-6BBE-4D5D-9047-8E44F72DE2E3Q58417407-F90BF5CC-41F9-48BB-8FAB-DD066039133A
P2860
Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effect
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Peroxisome proliferator-activa ...... , suggesting an adverse effect
@ast
Peroxisome proliferator-activa ...... , suggesting an adverse effect
@en
type
label
Peroxisome proliferator-activa ...... , suggesting an adverse effect
@ast
Peroxisome proliferator-activa ...... , suggesting an adverse effect
@en
prefLabel
Peroxisome proliferator-activa ...... , suggesting an adverse effect
@ast
Peroxisome proliferator-activa ...... , suggesting an adverse effect
@en
P2093
P2860
P1433
P1476
Peroxisome proliferator-activa ...... , suggesting an adverse effect
@en
P2093
Chunxiao Yu
Mingfeng Cao
Tingting Wang
Wenbin Chen
Xiaoming Zhou
P2860
P304
P356
10.1371/JOURNAL.PONE.0099245
P407
P50
P577
2014-06-13T00:00:00Z